Search research articles
Contact Us
Filters
Showing results (11-20 of 83) with videos related to
Page
of 9
Sort By:
The Review of Diabetic Studies : RDS
|
February 14, 2013
Immunotherapy in autoimmune type 1 diabetes
Benno Weigmann, Randi K Franke, Carolin Daniel
The Journal of Experimental Medicine
|
May 25, 2017
Reply to "Tolerogenic insulin peptide therapy precipitates type 1 diabetes"
Carolin Daniel, Benno Weigmann, Harald von Boehmer
Journal of Molecular Medicine (Berlin, Germany)
|
August 19, 2020
Role of the IL-2 inducible tyrosine kinase ITK and its inhibitors in disease pathogenesis
Kristina S Lechner, Markus F Neurath, Benno Weigmann
Expert Opinion on Drug Delivery
|
November 21, 2025
Interaction of nanodrug delivery systems via fibroblasts in colorectal cancer
Wenpeng Wang, Mingrui Li, Ying Liu, et al.
Journal of Inflammation Research
|
September 16, 2025
Quercetin-Loaded Nanoparticles: A Promising Therapeutic Strategy for Inflammatory Bowel Disease
Wenpeng Wang, Mingrui Li, Ying Liu, et al.
Cells
|
September 23, 2022
The Memory T Cell "Communication Web" in Context with Gastrointestinal Disorders-How Memory T Cells Affect Their Surroundings and How They Are Influenced by It
Annkathrin Knauss, Michael Gabel, Markus F Neurath, et al.
The Journal of Experimental Medicine
|
June 22, 2011
Prevention of type 1 diabetes in mice by tolerogenic vaccination with a strong agonist insulin mimetope
Carolin Daniel, Benno Weigmann, Roderick Bronson, et al.
Nature Protocols
|
April 5, 2007
Chemically induced mouse models of intestinal inflammation
Stefan Wirtz, Clemens Neufert, Benno Weigmann, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
August 21, 2013
Treg vaccination in autoimmune type 1 diabetes
Isabelle Serr, Benno Weigmann, Randi Kristina Franke, et al.
Tissue Barriers
|
April 4, 2015
IL-9 regulates intestinal barrier function in experimental T cell-mediated colitis
Katharina Gerlach, Andrew N McKenzie, Markus F Neurath, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 83) with videos related to
Sort By:
Page
of 9
The Review of Diabetic Studies : RDS
|
February 14, 2013
Immunotherapy in autoimmune type 1 diabetes
Benno Weigmann, Randi K Franke, Carolin Daniel
The Journal of Experimental Medicine
|
May 25, 2017
Reply to "Tolerogenic insulin peptide therapy precipitates type 1 diabetes"
Carolin Daniel, Benno Weigmann, Harald von Boehmer
Journal of Molecular Medicine (Berlin, Germany)
|
August 19, 2020
Role of the IL-2 inducible tyrosine kinase ITK and its inhibitors in disease pathogenesis
Kristina S Lechner, Markus F Neurath, Benno Weigmann
Expert Opinion on Drug Delivery
|
November 21, 2025
Interaction of nanodrug delivery systems via fibroblasts in colorectal cancer
Wenpeng Wang, Mingrui Li, Ying Liu, et al.
Journal of Inflammation Research
|
September 16, 2025
Quercetin-Loaded Nanoparticles: A Promising Therapeutic Strategy for Inflammatory Bowel Disease
Wenpeng Wang, Mingrui Li, Ying Liu, et al.
Cells
|
September 23, 2022
The Memory T Cell "Communication Web" in Context with Gastrointestinal Disorders-How Memory T Cells Affect Their Surroundings and How They Are Influenced by It
Annkathrin Knauss, Michael Gabel, Markus F Neurath, et al.
The Journal of Experimental Medicine
|
June 22, 2011
Prevention of type 1 diabetes in mice by tolerogenic vaccination with a strong agonist insulin mimetope
Carolin Daniel, Benno Weigmann, Roderick Bronson, et al.
Nature Protocols
|
April 5, 2007
Chemically induced mouse models of intestinal inflammation
Stefan Wirtz, Clemens Neufert, Benno Weigmann, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
August 21, 2013
Treg vaccination in autoimmune type 1 diabetes
Isabelle Serr, Benno Weigmann, Randi Kristina Franke, et al.
Tissue Barriers
|
April 4, 2015
IL-9 regulates intestinal barrier function in experimental T cell-mediated colitis
Katharina Gerlach, Andrew N McKenzie, Markus F Neurath, et al.
Page
of 9